1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6828A7C0466E10B5200258C0D00501685
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-effective-hematology-medical-insights-management-tools-activities-training?opendocument
18
19opendocument
2018.97.9.169
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




» Products & Services » » Medical Affairs » Medical Communication

Effective Hematology Medical Insights Management: Tools, Activities, and Training

ID: 5846


Features:

8 Info Graphics

47 Data Graphics

940+ Metrics

2 Narratives


Pages/Slides: 64


Published: 2025


Delivery Format: Online PDF Document


 

License Options:


Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from “Effective Hematology Medical Insights Management: Tools, Activities, and Training”

STUDY OVERVIEW

Hematology-focused Medical Affairs teams must have the right tools, well-coordinated activities, and targeted training to keep up with the rapid advancements and successfully disseminate insights. From leveraging technology to coordinating cross-functional efforts, success depends on robust systems tailored to meet evolving demands.

This Best Practices, LLC research identifies best practices for utilizing tools, conducting key activities, and designing training programs to enhance hematology insight collection and dissemination. The findings provide actionable benchmarks and innovative strategies to strengthen the efficiency and impact of Hematology Medical Affairs operations.

Benchmark data is broken down into two different segments to provide deeper insights. Classifications reflect their approach and standing in hematology medical insight generation: Insight Majority (18 respondents) and Insight Laggards (4 respondents).


KEY TOPICS

  • Hematology Insights Gathering Activities
  • Coordination for Hematology Insights Gathering
  • Training Techniques and Tools for Hematology Insights Gathering

KEY METRICS

  • Highly effective team coordination tactics and tools within Medical Affairs – Total benchmark class, Insight Majority, and Insight Laggards
  • Effectiveness of listed tactics and tools used by the Hematology Medical Affairs group to coordinate work, data, and analyses for stakeholders – Total benchmark class, Insight Majority, and Insight Laggards
  • Use of different tools for hematology insight gathering in Medical Affairs; Integration of insights into a unified platform using different tools
  • Percentage of intelligence gathering work involving primary (field) research and secondary research in hematology – Total benchmark class, Insight Majority, and Insight Laggards
  • Effectiveness and importance of primary and secondary data collection sources in hematology – Total benchmark class, Insight Majority, and Insight Laggards
  • Frequency of usage of primary and secondary sources for collecting intelligence data within Hematology Medical Affairs – Total benchmark class, Insight Majority, and Insight Laggards
  • Effectiveness of internal sources that support intelligence data collection in hematology – Total benchmark class, Insight Majority, and Insight Laggards
  • Functions and groups used within Hematology Medical Affairs organization to narrow the focus of the issue and discover information gaps – Total benchmark class, Insight Majority, and Insight Laggards
  • Internal limitations to receiving hematology medical insights
  • Effectiveness of training techniques for insights data collection in hematology – Total benchmark class, Insight Majority, and Insight Laggards

SAMPLE KEY FINDINGS

  • Primary and Secondary Data Sources: Expand the range of groups involved in data collection to enhance hematology insight generation. Internal sources benefit from deeper training to strengthen data accuracy, while secondary resources require advanced technology integration to improve data effectiveness and accessibility.

METHODOLOGY

Best Practices, LLC engaged 22 executives from 17 leading life sciences companies focused on hematology for this research. The study insights are mostly from directors and higher management executives, representing nearly 80% of the benchmark participants.

Industries Profiled:
Pharmaceutical; Biopharmaceutical; Communications; Manufacturing; Biotech; Consumer Products; Diagnostic; Medical Device; Chemical; Health Care


Companies Profiled:
Agios; Apellis Pharmaceuticals; ApotheCom; Bayer; Eli Lilly and Company; Genentech; Janssen; Merck; Mesoblast; Novo Nordisk; Orchard Therapeutics; Roche; Sandoz; Servier; Takeda Pharmaceuticals; Terumo BCT: Terumo Blood and Cell Technologies; Teva Pharmaceuticals

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.